Effectiveness of antiviral treatment of patients with chronic hepatitis C GT 1b depending on the presence of comorbid chronic renal insufficiency

Aim. The aim of the work was to analyze the effectiveness of antiviral therapy (3D mode) in patients with chronic hepatitis C (CHC) GT1 in clinical practice, depending on the presence of comorbid chronic renal insufficiency stage V, who receiving hemodialysis. Materials and methods. 101 patients...

Full description

Saved in:
Bibliographic Details
Main Authors: H. V. Venytska, O. V. Riabokon
Format: Article
Language:English
Published: Zaporizhzhia State Medical and Pharmaceutical University 2022-12-01
Series:Aktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki
Subjects:
Online Access:http://pharmed.zsmu.edu.ua/article/view/265483/264368
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849417519598665728
author H. V. Venytska
O. V. Riabokon
author_facet H. V. Venytska
O. V. Riabokon
author_sort H. V. Venytska
collection DOAJ
description Aim. The aim of the work was to analyze the effectiveness of antiviral therapy (3D mode) in patients with chronic hepatitis C (CHC) GT1 in clinical practice, depending on the presence of comorbid chronic renal insufficiency stage V, who receiving hemodialysis. Materials and methods. 101 patients with CHC GT1 who received antiviral therapy (AVT) according to the scheme OBV/PTV/r + DSV ± RBV (3D-mode) during 12 weeks were included in the study. All patients with CHC were divided into two groups depending on the presence of comorbid chronic renal insufficiency (CRI): 92 patients who did not have accompanying CRI and 9 patients with comorbid CRI stage V who received program hemodialysis. Results. The effectiveness of antiviral therapy in patients with CHC GT1 according to the OBV/PTV/r + DSV ± RBV scheme in clinical practice was high in terms of the achievement of 12 weeks sustained virologic response (SVR 12) SVR 12 (94.1 %). The frequency of achieving SVR 12 in CHC patients without concomitant CRI was 94.6 %, and with of comorbid CRI stage V (hemodialysis) – 88.9 % and had not statistically significant differences (P > 0.05). Treatment according to the 3D-mode was accompanied with stable normalization of ALT activity in 86.0 % of patients with CHC, and the frequency of it is achievement did not depend on the presence of comorbid CRI stage V (100.0 % vs. 85.2 % in patients without the specified concomitant pathology, P > 0.05). Conclusions. The effectiveness of antiviral therapy in patients with CHC GT1 according to the OBV/PTV/r + DSV ± RBV scheme in clinical practice is high in terms of the achievement of SVR 12 (94.1 %) and does not depend in the presence of comorbid CRI stage V in the patient (94.6 % vs. 88.9 %, P > 0.05). The severity of liver fibrosis does not affect the effectiveness of AVT in patients with CHC GT1 in the presence of comorbid CRI stage V and without this comorbid condition.
format Article
id doaj-art-0c7effbdb52c40ea928a47ad3866b35d
institution Kabale University
issn 2306-8094
2409-2932
language English
publishDate 2022-12-01
publisher Zaporizhzhia State Medical and Pharmaceutical University
record_format Article
series Aktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki
spelling doaj-art-0c7effbdb52c40ea928a47ad3866b35d2025-08-20T03:32:47ZengZaporizhzhia State Medical and Pharmaceutical UniversityAktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki2306-80942409-29322022-12-0115330130610.14739/2409-2932.2022.3.265483Effectiveness of antiviral treatment of patients with chronic hepatitis C GT 1b depending on the presence of comorbid chronic renal insufficiencyH. V. Venytska0https://orcid.org/0000-0002-3642-0117O. V. Riabokon1https://orcid.org/0000-0002-7394-4649Zaporizhzhia State Medical University, UkraineZaporizhzhia State Medical University, UkraineAim. The aim of the work was to analyze the effectiveness of antiviral therapy (3D mode) in patients with chronic hepatitis C (CHC) GT1 in clinical practice, depending on the presence of comorbid chronic renal insufficiency stage V, who receiving hemodialysis. Materials and methods. 101 patients with CHC GT1 who received antiviral therapy (AVT) according to the scheme OBV/PTV/r + DSV ± RBV (3D-mode) during 12 weeks were included in the study. All patients with CHC were divided into two groups depending on the presence of comorbid chronic renal insufficiency (CRI): 92 patients who did not have accompanying CRI and 9 patients with comorbid CRI stage V who received program hemodialysis. Results. The effectiveness of antiviral therapy in patients with CHC GT1 according to the OBV/PTV/r + DSV ± RBV scheme in clinical practice was high in terms of the achievement of 12 weeks sustained virologic response (SVR 12) SVR 12 (94.1 %). The frequency of achieving SVR 12 in CHC patients without concomitant CRI was 94.6 %, and with of comorbid CRI stage V (hemodialysis) – 88.9 % and had not statistically significant differences (P > 0.05). Treatment according to the 3D-mode was accompanied with stable normalization of ALT activity in 86.0 % of patients with CHC, and the frequency of it is achievement did not depend on the presence of comorbid CRI stage V (100.0 % vs. 85.2 % in patients without the specified concomitant pathology, P > 0.05). Conclusions. The effectiveness of antiviral therapy in patients with CHC GT1 according to the OBV/PTV/r + DSV ± RBV scheme in clinical practice is high in terms of the achievement of SVR 12 (94.1 %) and does not depend in the presence of comorbid CRI stage V in the patient (94.6 % vs. 88.9 %, P > 0.05). The severity of liver fibrosis does not affect the effectiveness of AVT in patients with CHC GT1 in the presence of comorbid CRI stage V and without this comorbid condition.http://pharmed.zsmu.edu.ua/article/view/265483/264368chronic hepatitis cviral infectioncomorbiditychronic renal insufficiencyhemodialysisantiviral treatment
spellingShingle H. V. Venytska
O. V. Riabokon
Effectiveness of antiviral treatment of patients with chronic hepatitis C GT 1b depending on the presence of comorbid chronic renal insufficiency
Aktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki
chronic hepatitis c
viral infection
comorbidity
chronic renal insufficiency
hemodialysis
antiviral treatment
title Effectiveness of antiviral treatment of patients with chronic hepatitis C GT 1b depending on the presence of comorbid chronic renal insufficiency
title_full Effectiveness of antiviral treatment of patients with chronic hepatitis C GT 1b depending on the presence of comorbid chronic renal insufficiency
title_fullStr Effectiveness of antiviral treatment of patients with chronic hepatitis C GT 1b depending on the presence of comorbid chronic renal insufficiency
title_full_unstemmed Effectiveness of antiviral treatment of patients with chronic hepatitis C GT 1b depending on the presence of comorbid chronic renal insufficiency
title_short Effectiveness of antiviral treatment of patients with chronic hepatitis C GT 1b depending on the presence of comorbid chronic renal insufficiency
title_sort effectiveness of antiviral treatment of patients with chronic hepatitis c gt 1b depending on the presence of comorbid chronic renal insufficiency
topic chronic hepatitis c
viral infection
comorbidity
chronic renal insufficiency
hemodialysis
antiviral treatment
url http://pharmed.zsmu.edu.ua/article/view/265483/264368
work_keys_str_mv AT hvvenytska effectivenessofantiviraltreatmentofpatientswithchronichepatitiscgt1bdependingonthepresenceofcomorbidchronicrenalinsufficiency
AT ovriabokon effectivenessofantiviraltreatmentofpatientswithchronichepatitiscgt1bdependingonthepresenceofcomorbidchronicrenalinsufficiency